You can go to Bloomberg or CNBC but this gilead trial was quoted as the reason. Although early in their trials, they are " highly encouraged by the results to treat the symptoms " .
This is what's being reported here in the states.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.73 |
Change
0.170(2.25%) |
Mkt cap ! $5.596B | |||
| Open | High | Low | Value | Volume |
| $7.59 | $7.74 | $7.58 | $16.59M | 2.161M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14551 | $7.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.73 | 1355 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |